SG11201702395WA - Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease - Google Patents
Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac diseaseInfo
- Publication number
- SG11201702395WA SG11201702395WA SG11201702395WA SG11201702395WA SG11201702395WA SG 11201702395W A SG11201702395W A SG 11201702395WA SG 11201702395W A SG11201702395W A SG 11201702395WA SG 11201702395W A SG11201702395W A SG 11201702395WA SG 11201702395W A SG11201702395W A SG 11201702395WA
- Authority
- SG
- Singapore
- Prior art keywords
- disease
- systems
- methods
- inflammatory bowel
- bowel syndrome
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462061877P | 2014-10-09 | 2014-10-09 | |
US201462085825P | 2014-12-01 | 2014-12-01 | |
PCT/US2015/054655 WO2016057772A1 (en) | 2014-10-09 | 2015-10-08 | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201702395WA true SG11201702395WA (en) | 2017-04-27 |
Family
ID=55653760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201702395WA SG11201702395WA (en) | 2014-10-09 | 2015-10-08 | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
Country Status (13)
Country | Link |
---|---|
US (2) | US10132814B2 (en) |
EP (1) | EP3204771A4 (en) |
JP (1) | JP6784669B2 (en) |
KR (1) | KR102426541B1 (en) |
CN (1) | CN107003308B (en) |
AU (1) | AU2015330872B2 (en) |
CA (1) | CA2962493C (en) |
IL (1) | IL251606B (en) |
MX (1) | MX2017004516A (en) |
NZ (1) | NZ730490A (en) |
RU (1) | RU2706361C2 (en) |
SG (1) | SG11201702395WA (en) |
WO (1) | WO2016057772A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9851361B2 (en) | 2013-10-09 | 2017-12-26 | Cedars-Sinai Medical Center | Methods of comparing anti-vinculin and anti-cytolethal distending toxin antibodies as they relate to irritable bowel syndrome |
US9869676B2 (en) | 2009-02-11 | 2018-01-16 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
US10132814B2 (en) | 2014-10-09 | 2018-11-20 | Cedars-Sinai Medical Center | Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
US10466254B2 (en) | 2012-09-17 | 2019-11-05 | Cedars-Sinai Medical Center | Method of measuring a level of anti-vinculin antibodies in a biological sample |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11693009B2 (en) | 2009-02-11 | 2023-07-04 | Cedars-Sinai Medical Center | Methods for detecting post-infectious irritable bowel syndrome |
EP3913371A1 (en) | 2020-05-18 | 2021-11-24 | Neuroimmun GmbH | Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions |
CN113447649B (en) * | 2021-07-01 | 2022-04-19 | 浙江大学 | Kit for detecting anti-adhesion plaque protein-IgG antibody |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5691151A (en) | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
FR2806805A1 (en) | 2000-03-22 | 2001-09-28 | Centre Nat Rech Scient | PEPTIDE SEQUENCE COMPRISING ONE OR MORE REASONS FOR BINDING PROTEINS OF THE ENA / VASP FAMILY AND USES THEREOF |
AU2003233576A1 (en) | 2002-05-17 | 2003-12-02 | Sugen, Inc. | Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
EP2444409A2 (en) | 2002-09-16 | 2012-04-25 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
US7595386B2 (en) | 2003-01-24 | 2009-09-29 | William Beaumont Hospital | Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
JP4711963B2 (en) | 2003-09-15 | 2011-06-29 | オクラホマ メディカル リサーチ ファウンデーション | Methods using cytokine assays to diagnose, treat and evaluate inflammatory and autoimmune diseases |
ES2456710T3 (en) | 2003-12-05 | 2014-04-23 | Fuso Pharmaceutical Industries Ltd. | Cytoletal distention toxin genes as targets for the detection of Campylobacter bacteria |
US20080085524A1 (en) | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
EP2102367A2 (en) | 2006-11-09 | 2009-09-23 | XDX, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
ES2391792T3 (en) | 2007-12-20 | 2012-11-29 | Index Diagnostics Ab (Publ) | Method for the differentiation of IBD and IBS and the additional distinction between pathological types of IBD |
WO2010045180A1 (en) | 2008-10-13 | 2010-04-22 | Metabolon, Inc. | Biomarkers for inflammatory bowel disease and methods using the same |
EP2370435B1 (en) | 2008-11-24 | 2015-01-07 | Cedars-Sinai Medical Center | Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof |
NO2396652T3 (en) | 2009-02-11 | 2018-05-12 | ||
WO2010093776A1 (en) | 2009-02-11 | 2010-08-19 | Cedars-Sinai Medical Center | Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome |
FR2942541A1 (en) | 2009-02-25 | 2010-08-27 | Assist Publ Hopitaux De Paris | METHOD FOR DIAGNOSING A VASCULARITY |
RU2397178C1 (en) * | 2009-02-27 | 2010-08-20 | Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Diagnostic test system in immunochip format and differential serum diagnostics of syphilis |
IT1400989B1 (en) | 2010-07-13 | 2013-07-05 | Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L | FORMS OF ORAL ADMINISTRATION WITH RELEASED RELEASE OF REFINING SIDE FOR THE TREATMENT OF BACTERIAL INFECTIONS OF THE INTESTINAL SYSTEM. |
GB201017520D0 (en) | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
JP5477671B2 (en) | 2012-02-28 | 2014-04-23 | 三菱マテリアル株式会社 | Metal nitride material for thermistor, manufacturing method thereof, and film type thermistor sensor |
KR102203568B1 (en) * | 2012-09-17 | 2021-01-15 | 세다르스-신나이 메디칼 센터 | Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia |
EP3054977B1 (en) | 2013-10-09 | 2021-07-21 | Cedars-Sinai Medical Center | Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease |
RU2706361C2 (en) | 2014-10-09 | 2019-11-18 | Седарс-Синаи Медикал Сентер | Methods and systems for distinguishing irritable bowel syndrome from inflammatory intestinal disease and gluten disease |
EP3573650A4 (en) | 2017-01-30 | 2020-12-09 | Cedars-Sinai Medical Center | Diagnosis of scleroderma |
-
2015
- 2015-10-08 RU RU2017115663A patent/RU2706361C2/en active IP Right Revival
- 2015-10-08 KR KR1020177011301A patent/KR102426541B1/en active IP Right Grant
- 2015-10-08 JP JP2017518834A patent/JP6784669B2/en active Active
- 2015-10-08 SG SG11201702395WA patent/SG11201702395WA/en unknown
- 2015-10-08 EP EP15849701.6A patent/EP3204771A4/en active Pending
- 2015-10-08 WO PCT/US2015/054655 patent/WO2016057772A1/en active Application Filing
- 2015-10-08 AU AU2015330872A patent/AU2015330872B2/en active Active
- 2015-10-08 MX MX2017004516A patent/MX2017004516A/en unknown
- 2015-10-08 US US14/878,416 patent/US10132814B2/en active Active
- 2015-10-08 CA CA2962493A patent/CA2962493C/en active Active
- 2015-10-08 NZ NZ730490A patent/NZ730490A/en unknown
- 2015-10-08 CN CN201580067387.5A patent/CN107003308B/en active Active
-
2017
- 2017-04-05 IL IL251606A patent/IL251606B/en active IP Right Grant
-
2018
- 2018-10-05 US US16/152,806 patent/US10690679B2/en active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9869676B2 (en) | 2009-02-11 | 2018-01-16 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
US10527621B2 (en) | 2009-02-11 | 2020-01-07 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
US10466254B2 (en) | 2012-09-17 | 2019-11-05 | Cedars-Sinai Medical Center | Method of measuring a level of anti-vinculin antibodies in a biological sample |
US9851361B2 (en) | 2013-10-09 | 2017-12-26 | Cedars-Sinai Medical Center | Methods of comparing anti-vinculin and anti-cytolethal distending toxin antibodies as they relate to irritable bowel syndrome |
US10352944B2 (en) | 2013-10-09 | 2019-07-16 | Cedars-Sinai Medical Center | Method of determinig levels of anti-vinculin and anti-cytolethal distending toxin antibodies in subjects desiring to distinguish irritable bowel syndrome from inflammatory bowel disease |
US10132814B2 (en) | 2014-10-09 | 2018-11-20 | Cedars-Sinai Medical Center | Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
US10690679B2 (en) | 2014-10-09 | 2020-06-23 | Cedars-Sinai Medical Center | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
Also Published As
Publication number | Publication date |
---|---|
CN107003308B (en) | 2020-02-11 |
IL251606B (en) | 2020-08-31 |
CA2962493A1 (en) | 2016-04-14 |
AU2015330872B2 (en) | 2021-04-22 |
RU2017115663A3 (en) | 2019-05-16 |
US20160103136A1 (en) | 2016-04-14 |
US10132814B2 (en) | 2018-11-20 |
WO2016057772A1 (en) | 2016-04-14 |
IL251606A0 (en) | 2017-06-29 |
EP3204771A1 (en) | 2017-08-16 |
JP2017531801A (en) | 2017-10-26 |
RU2017115663A (en) | 2018-11-13 |
MX2017004516A (en) | 2017-10-12 |
RU2706361C2 (en) | 2019-11-18 |
US20190187153A1 (en) | 2019-06-20 |
EP3204771A4 (en) | 2018-03-14 |
JP6784669B2 (en) | 2020-11-11 |
CN107003308A (en) | 2017-08-01 |
CA2962493C (en) | 2023-01-10 |
AU2015330872A1 (en) | 2017-04-13 |
KR20170067795A (en) | 2017-06-16 |
NZ730490A (en) | 2021-07-30 |
US10690679B2 (en) | 2020-06-23 |
KR102426541B1 (en) | 2022-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL257857A (en) | Clot retrieval system | |
SG11201701855RA (en) | Systems and methods for liveness analysis | |
SG11201606716VA (en) | Video analysis system | |
GB201517055D0 (en) | An acoustic detection system | |
GB2525011B (en) | Cooking system | |
GB2533284B (en) | Performing object detection | |
IL251606B (en) | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease | |
GB201408100D0 (en) | Detection method | |
GB201402644D0 (en) | Methylation detection method | |
GB201409766D0 (en) | Signal processing methods | |
GB201418499D0 (en) | Malware detection method | |
ZA201607571B (en) | Compositions and methods for detecting huanglongbing | |
IL259904A (en) | Multi-threat detection system | |
GB201504373D0 (en) | Computer system testing | |
GB201409182D0 (en) | Capacitive detection system | |
ZA201701382B (en) | Lexical dialect analysis system | |
GB201419330D0 (en) | Detection method | |
GB201903180D0 (en) | Fire detection device | |
SG10201406350UA (en) | An event detection method | |
GB201416459D0 (en) | Detection method | |
GB201707731D0 (en) | Detection system | |
SG11201610262TA (en) | Object detection system | |
SG11201508484QA (en) | Charging processing system | |
GB201402174D0 (en) | Detection method | |
GB201516218D0 (en) | Detection system |